Ligand profile
2W2
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_01017 — Lysine-arginine-ornithine-binding periplasmic protein
Identifiers
Database identifiers and provenance.
- Ligand ID
2W2- PDB
5ovz- UniProt (similar protein)
P35120- Target protein
- KP13_01017
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 185.8
- −1 ≤ LogP ≤ 5 -1.39
- MW ≤ 500 Da 304.3
- LogP ≤ 5 -1.39
- H-bond donors ≤ 5 7
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 185.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
[H]/N=C(/N)\NCCC[C@@H](C(=O)O)N[C@H](CCC(=O)O)C(=O)O[H]/N=C(/N)\NCCC[C@@H](C(=O)O)N[C@H](CCC(=O)O)C(=O)O
InChI=1S/C11H20N4O6/c12-11(13)14-5-1-2-6(9(18)19)15-7(10(20)21)3-4-8(16)17/h6-7,15H,1-5H2,(H,16,17)(H,18,19)(H,20,21)(H4,12,13,14)/t6-,7+/m0/s1InChI=1S/C11H20N4O6/c12-11(13)14-5-1-2-6(9(18)19)15-7(10(20)21)3-4-8(16)17/h6-7,15H,1-5H2,(H,16,17)(H,18,19)(H,20,21)(H4,12,13,14)/t6-,7+/m0/s1
LMKYZBGVKHTLTN-NKWVEPMBSA-NLMKYZBGVKHTLTN-NKWVEPMBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00497
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 2W2 →
- PDB RCSB structure 5ovz →
- UniProt UniProt P35120 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “2W2”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01017.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).